Two Sigma Securities’s VanEck Biotech ETF BBH Stock Holding History

Two Sigma Securities’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,465	Closed	-$230K	–	1475
2024 Q4	$230K	Buy	+1,465	New	+$246K	0.03%	857
2018 Q1	–	Sell	-1,947	Closed	-$243K	–	2669
2017 Q4	$243K	Buy	+1,947	New	+$249K	0.01%	1160
2015 Q2	–	Sell	-1,795	Closed	-$233K	–	182
2015 Q1	$233K	Buy	+1,795	New	+$226K	0.24%	99

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

Two Sigma Securities's BBH Position: Q1 2025 in Review

Two Sigma Securities sold out of VanEck Biotech ETF (BBH) in Q1 2025, closing a stake of 1,465 shares — an estimated $230K sold.

Two Sigma Securities first reported a position in BBH in Q1 2015 and held it in 3 quarters. The position peaked at $243K in Q4 2017. 104 funds tracked by Wall St. Rank hold BBH as of Q1 2025.

Two Sigma Securities reported no remaining VanEck Biotech ETF position as of Q1 2025 after selling out during the quarter.
Two Sigma Securities sold 1,465 VanEck Biotech ETF shares in Q1 2025, an estimated $230K.
Two Sigma Securities first reported a position in VanEck Biotech ETF in Q1 2015 and held it in 3 quarters.
Two Sigma Securities's VanEck Biotech ETF position peaked at $243K in Q4 2017.
104 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2025.

Based on Two Sigma Securities's 13F filing for Q1 2025, filed 15 May 2025.